澳大利亚的研究人员开发纳米粒子,以加强对三阴性乳腺癌的免疫反应。 Researchers in Australia develop nanoparticles to enhance immune response against triple-negative breast cancer.

澳大利亚的研究人员正在研制铁基纳米粒子,以改进治疗三阴性乳腺癌(TNBC),这是一种特别具有攻击性的疾病。 Researchers in Australia are developing iron-based nanoparticles to improve treatments for triple-negative breast cancer (TNBC), a particularly aggressive form of the disease. 这些纳米粒子旨在通过增强T细胞的活动,提高免疫系统识别和攻击癌症细胞的能力。 These nanoparticles aim to boost the immune system's ability to recognize and attack cancer cells by enhancing T-cell activity. 该项目由300万美元的赠款资助,力求为TNBC和可能的其他难以治疗的癌症如卵巢癌提供新的解决办法。 Funded by a $3 million grant, the project seeks to provide new solutions for TNBC and potentially other hard-to-treat cancers like ovarian cancer.